Luminescence enhancement effect for the determination of balofloxacin with balofloxacin-europium (III)-sodium dodecylbenzene sulfonate system

被引:13
作者
Wang, Lei [1 ]
Guo, Changchuan [1 ]
Chu, Zhijie [1 ]
Jiang, Wei [2 ]
机构
[1] Shandong Univ, Sch Pharm, Jinan 250012, Peoples R China
[2] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China
关键词
Balofloxacin; Europium; Determination; Luminescence; FLUOROQUINOLONE BALOFLOXACIN; HUMAN SERUM; FLUORESCENCE; PHARMACOKINETICS; QUINOLONES; 8-POSITION; Q-35;
D O I
10.1016/j.jlumin.2008.08.006
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
A novel method of luminescence enhancement effect for the determination of balofloxacin (BLFX) was proposed. A new system of the BLFX-Eu3+-SDBS (sodium dodecylbenzene sulfonate) was investigated. It was found that SDBS significantly enhanced the luminescence intensity of the BLFX-Eu3+ complex (about 20-fold). Under the optimized experimental conditions, the system exhibits an excellent linear relationship between the enhanced luminescence intensity and the concentration of BLFX over the range of 1.0 x 10(-8)-8.0 x 10(-7) mol L-1 with a correlation coefficient (R) of 0.9994. and the detection limit (3 sigma) of the method was determined as 2.0 x 10(-9) mol L-1. This method has been successfully applied for the determination of BLFX in pharmaceuticals and human urine/serum samples. Compared with most of the other methods reported, the rapid and simple procedure proposed in the text offers higher sensitivity, wider linear range, and better stability. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 18 条
[1]  
Alksne Lefa, 2003, Curr Opin Investig Drugs, V4, P224
[2]   High performance liquid chromatography-electrospray ionization mass spectrometric determination of balofloxacin in human plasma and its pharmacokinetics [J].
Bian, Zuwei ;
Tian, Yuan ;
Zhang, Zunjian ;
Xu, Fengguo ;
Li, Jinheng ;
Cao, Xiaomei .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 850 (1-2) :68-73
[3]   Taking advantage of luminescent lanthanide ions [J].
Bünzli, JCG ;
Piguet, C .
CHEMICAL SOCIETY REVIEWS, 2005, 34 (12) :1048-1077
[4]   Study of the influence of silver nanoparticles on the second-order scattering and the fluorescence of the complexes of Tb(III) with quinolones and determination of the quinolones [J].
Ding, F ;
Zhao, HC ;
Jin, LP ;
Zheng, D .
ANALYTICA CHIMICA ACTA, 2006, 566 (01) :136-143
[5]   IN-VITRO AND IN-VIVO ACTIVITIES OF Q-35, A NEW FLUOROQUINOLONE, AGAINST MYCOPLASMA-PNEUMONIAE [J].
GOHARA, Y ;
ARAI, S ;
AKASHI, A ;
KUWANO, K ;
TSENG, CC ;
MATSUBARA, S ;
MATUMOTO, M ;
FURUDERA, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1826-1830
[6]   INVITRO ANTIBACTERIAL ACTIVITY OF Q-35, A NEW FLUOROQUINOLONE [J].
ITO, T ;
OTSUKI, M ;
NISHINO, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1708-1714
[7]  
Kahn, 2001, CHEMOTHERAPY, V47, P44
[8]   Comparative study of pharmacokinetics of two new fluoroquinolones, balofloxacin and grepafloxacin, in elderly subjects [J].
Kozawa, O ;
Uematsu, T ;
Matsuno, H ;
Niwa, M ;
Nagashima, S ;
Kanamaru, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2824-2828
[9]   Photoallergenicity of a fluoroquinolone antibacterial agent with a fluorine substituent at the 8-position in guinea pigs exposed to long-wavelength UV light [J].
Marutani, K ;
Otabe, Y ;
Nagamuta, M ;
Matsubara, S ;
Otani, H .
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 1998, 11 (4-5) :232-240
[10]   PHOTOSTABILITY AND BIOLOGICAL-ACTIVITY OF FLUOROQUINOLONES SUBSTITUTED AT THE 8-POSITION AFTER UV IRRADIATION [J].
MATSUMOTO, M ;
KOJIMA, K ;
NAGANO, H ;
MATSUBARA, S ;
YOKOTA, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1715-1719